Original Founders of Akkermansia Muciniphila Bring First Gut Health Product to U.S. Consumer Market The Akkermansia Company, founded by the first scientists to discover and decode Akkermansia muciniphila, announces its launch into the U.S. consumer market

Global Next Generation Probiotics Market to Surpass US$ 393.9 Million by 2030, Says Coherent Market Insights (CMI) Burlingame, Feb. 14, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global next generation probiotics market is estimated to be valued at US$ 168.1 million in 2022 and is...

Pan-Biome Pharmaceuticals, Inc. provides update on its longevity research program: its compounds modulate inflammation, the gut microbiome, and increase lifespan of C. elegans by 30% VANCOUVER, British Columbia, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc., a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...

Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...